Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
This study has been completed.
Study NCT00044707   Information provided by Amylin Pharmaceuticals, Inc.
First Received: September 3, 2002   Last Updated: December 14, 2007   History of Changes

September 3, 2002
December 14, 2007
August 2002
 
 
 
Complete list of historical versions of study NCT00044707 on ClinicalTrials.gov Archive Site
 
 
 
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
 

This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication

 
Phase II
Interventional
Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Pharmacokinetics Study
Diabetes Mellitus, Non-Insulin-Dependent
Drug: Pramlintide acetate
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
24
 
 

Inclusion Criteria:

  • Type 2 diabetes mellitus treated with diet and/or oral agents
  • HbA1c 6.5-11.0
Both
18 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00044707
 
137-154
Amylin Pharmaceuticals, Inc.
 
 
Amylin Pharmaceuticals, Inc.
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP